Jeff D Colbert, Ph.D.

Jeff D Colbert, Ph.D. has extensive experience in immunology and immune response research. Jeff D is currently serving as the Associate Director of Immuno-Oncology at Normunity, a role they started in 2022. Prior to this, they worked as an Immunologist at Immunitas Therapeutics from 2021 to 2022.

From 2018 to 2021, Jeff worked as an Instructor at the University of Massachusetts Medical School, where they collaborated with Dr. Kenneth Rock, MD, to study functional immunity and immune escape mechanisms in infection and cancer. Jeff D employed a genome-wide CRISPR approach to identify genes that regulate CD8 T cell immunity. Before that, from 2010 to 2018, they were a Postdoctoral Fellow at the same institution, continuing their research on immune cell inflammatory responses and immune surveillance of infection and cancer using a genome-wide siRNA screen and CRISPR approach.

Jeff's career also includes a position as a Postdoctoral Fellow at the University of Dundee from 2005 to 2010, where they worked with Dr. Colin Watts, Ph.D. Additionally, they served as a Graduate Student at the University of Colorado at Denver and Health Sciences Center and National Jewish Health from 1999 to 2005, focusing on studying inflammatory signals mediated through tumor necrosis factor (TNF) in pulmonary disease and exploring the temporal and spatial distinction between pro-inflammatory and pro-apoptotic signals.

Overall, Jeff D Colbert, Ph.D. has been dedicated to advancing the understanding of immune response mechanisms and their implications in infection, cancer, and inflammatory diseases throughout their career.

Jeff D Colbert, Ph.D. completed their Bachelor of Science (B.S.) in Microbiology and Molecular Biology at Kansas State University from 1991 to 1996. Following that, they pursued their Doctor of Philosophy (Ph.D.) in Immunology and Cell Biology at the University of Colorado Anschutz Medical Campus, graduating in the year 2005.